Two Sigma Securities’s Biofrontera BFRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,476
Closed -$7.68K 1670
2025
Q4
$7.68K Sell
13,476
-7,311
-35% -$6.61K ﹤0.01% 1316
2025
Q3
$20.5K Buy
+20,787
New +$18.8K ﹤0.01% 1136
2025
Q2
Sell
-11,253
Closed -$9K 1520
2025
Q1
$9K Sell
11,253
-6,803
-38% -$7K ﹤0.01% 1246
2024
Q4
$19.7K Buy
+18,056
New +$17.1K ﹤0.01% 1325

Other funds holding BFRI

Two Sigma Securities's BFRI Position: Q1 2026 in Review

Two Sigma Securities sold out of Biofrontera (BFRI) in Q1 2026, closing a stake of 13,476 shares — an estimated $7.68K sold.

Two Sigma Securities first reported a position in BFRI in Q4 2024 and held it in 4 quarters. The position peaked at $20.5K in Q3 2025. 12 funds tracked by Wall St. Rank hold BFRI as of Q1 2026.

  • Two Sigma Securities reported no remaining Biofrontera position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 13,476 Biofrontera shares in Q1 2026, an estimated $7.68K.
  • Two Sigma Securities first reported a position in Biofrontera in Q4 2024 and held it in 4 quarters.
  • Two Sigma Securities's Biofrontera position peaked at $20.5K in Q3 2025.
  • 12 funds tracked by Wall St. Rank held Biofrontera as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.